NCT06216600Recruiting
Women Focused Encounters for Resilience Independence Strength and Eudaimonia
Source: ClinicalTrials.gov · Last updated 1 May 2026
Brief summary (registry, in English)
The goal of this combination Type 1 hybrid and observational study is to evaluate the impact of a peer delivered intervention of acceptance and commitment therapy (ACT) + exercise + social support to address the substance (ab)use, violence, and AIDS/HIV (SAVA) to improve medication adherence for women living with HIV (WLWH). This intervention will be implemented by community based organizations that focus on WLWH across four counties. The main question it aims to answer are: * Will peer provision of ACT, exercise, and social support improve medication adherence for WLWH? * Will community based organizations be able to sustain the intervention after research is completed, and what changes will need to be made to sustain the intervention.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 300 (estimated)
- First submitted
- 11 Jan 2024
- Start date
- 19 Sept 2024
- Primary completion date
- 31 Dec 2027
- Lead sponsor
- University of California, San Diego
- Diseases
- HIV
- NCT number
- NCT06216600
What you commit to
- Study type: Interventional
- Planned participants: 300
- From 19 Sept 2024 to the primary completion date, 31 Dec 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Unwilling to participate in video record sessions (used to evaluate the quality of the intervention)
- Enrolled in hospice
- Not willing or not able to comply with study advisory board group participation agreement.
Who the study is looking for
- Is a woman
- Able to read and understand English
- Able to participate in a low intensity exercise program
- HIV-seropositive
- At risk substance use (any illegal or unprescribed drug), tobacco, marijuana or alcohol use (four or more drinks in one day or 8 or more in one week).
- Reports missing more ART doses than previous months, or \> 5 in a month, or has a detectable HIV viral load
- Experienced interpersonal violence
- Able and willing to provide informed consent
Age in the registry: 18 years to - · Sex: Female · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| UC San Diego AntiViral Research Center (AVRC) Coordinator of this site? Confirm its status | San Diego | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.